-IPS News NEW DELHI: Despite being one of the world's fastest expanding economies, projected to clock seven-percent GDP growth in 2017, India - a nation of 1.2 billion - is trailing behind on many vital social development indices while also hosting one-fourth of the world's poor. While the United Nations prepares to wrap up a decade-and-a-half of poverty alleviation efforts, framed through the lens of the Millennium Development Goals (MDGs), by the...

-Outlook The BJP government needs to understand that "vikas" means growth and development, not growth alone. The new government that came to power with the promise of "vikas" has launched an unrelenting attack on social welfare programmes and legislations. In October 2014, there was a rumour that NREGA would be restricted to some districts. Though the changes proposed have not been implemented, NREGA is in danger of dying a slow death...

-The Times of India NEW DELHI: The government is reviewing the tax-free medical reimbursement limit, currently fixed at Rs 15,000 a year, besides looking at making it more attractive for individuals to buy medical insurance policies. Sources said both the issues are being looked at ahead of the Budget with some indicating that there is a possibility that the limit on tax-free medical reimbursement from employers may be raised to Rs 25,000...

-The Hindustan Times The drafting of the National Health Policy (NHP) 2015 is an extremely welcome development. The government's decision to announce Health as a Right is a huge advance. Public health spending as a share of GDP barely rose from 0.9 to 1.1% under the previous government. Governments in rich countries have been spending 5% of GDP on health for decades. Why should we welcome the NHP 2015? Countries with...

-The Hindu Tropical diseases have often been neglected by pharmaceuticals because the size of the drug market is smaller, people have lower incomes and companies are uncertain about IPR January marked an important breakthrough in the fight against tropical diseases. Researchers and the International Centre for Genetic Engineering and Biotechnology (ICGEB) in Delhi found a drug candidate that prevented TB and malaria pathogens from infecting human blood cells. It is not just that...